SkinBioTherapeutics plc (AIM:SBTX)
London · Delayed Price · Currency is GBP · Price in GBX 9.70
+0.20 (2.11%)
Sep 4, 2026, 3:21 PM GMT
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 24.62 million as of September 4, 2026. Its market cap has decreased by -35.50% in one year.
Market Cap
24.62M
Enterprise Value
22.44M
Revenue
5.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.70
ChartMarket Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 24.62M, an increase of 56.53%. That is a compound annual growth rate of 4.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 24.62M | -39.59% |
| Dec 31, 2025 | 40.76M | -3.56% |
| Dec 31, 2024 | 42.26M | 45.57% |
| Dec 29, 2023 | 29.03M | 8.17% |
| Dec 30, 2022 | 26.84M | -59.24% |
| Dec 31, 2021 | 65.85M | 79.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ondine Biomedical | 59.75M |
| Sareum Holdings | 48.50M |
| hVIVO | 47.40M |
| Hemogenyx Pharmaceuticals | 35.63M |
| Arecor Therapeutics | 27.94M |
| ImmuPharma | 21.87M |
| Palatin Technologies | 16.44M |
| IXICO | 16.35M |